Showing 1 - 12 results of 12 for search 'Ren-Wang Peng', query time: 0.04s
Refine Results
-
1
CRISPRing <i>KRAS</i>: A Winding Road with a Bright Future in Basic and Translational Cancer Research by Xian Gong, Jianting Du, Ren-Wang Peng, Chun Chen, Zhang Yang
Published 2024-01-01
Article -
2
-
3
A Breakthrough Brought about by Targeting KRAS<sup>G12C</sup>: Nonconformity Is Punished by Wenjuan Ning, Zhang Yang, Gregor J. Kocher, Patrick Dorn, Ren-Wang Peng
Published 2022-01-01
Article -
4
Beyond DNA Repair: DNA-PKcs in Tumor Metastasis, Metabolism and Immunity by Haitang Yang, Feng Yao, Thomas M. Marti, Ralph A. Schmid, Ren-Wang Peng
Published 2020-11-01
Article -
5
-
6
-
7
-
8
-
9
NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma by Haitang Yang, Sean R. R. Hall, Beibei Sun, Liang Zhao, Yanyun Gao, Ralph A. Schmid, Swee T. Tan, Ren-Wang Peng, Feng Yao
Published 2021-03-01
Article -
10
Endoplasmic Reticulum Stress Signaling as a Therapeutic Target in Malignant Pleural Mesothelioma by Duo Xu, Haitang Yang, Zhang Yang, Sabina Berezowska, Yanyun Gao, Shun-Qing Liang, Thomas M. Marti, Sean R. R. Hall, Patrick Dorn, Gregor J. Kocher, Ralph A. Schmid, Ren-Wang Peng
Published 2019-10-01
Article -
11
Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer by Zhang Yang, Shun-Qing Liang, Liang Zhao, Haitang Yang, Thomas M. Marti, Balazs Hegedüs, Yanyun Gao, Bin Zheng, Chun Chen, Wenxiang Wang, Patrick Dorn, Gregor J. Kocher, Ralph A. Schmid, Ren-Wang Peng
Published 2022-01-01
Article -
12
Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS‐mutant cancer by Zhang Yang, Shun‐Qing Liang, Maria Saliakoura, Haitang Yang, Eric Vassella, Georgia Konstantinidou, Mario Tschan, Balazs Hegedüs, Liang Zhao, Yanyun Gao, Duo Xu, Haibin Deng, Thomas M Marti, Gregor J Kocher, Wenxiang Wang, Ralph A Schmid, Ren‐Wang Peng
Published 2021-09-01
Article